NYSCF Press Releases
NEW YORK, NY (May 14, 2012) -- Dr. Darja Marolt, an Investigator at The New York Stem Cell Foundation (NYSCF) Laboratory, is lead author on a study showing that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application. Dr.…
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco NEW YORK, NY (January 9, 2012) – Susan L. Solomon, CEO of The New York Stem Cell Foundation (NYSCF), will speak on the state of the industry of regenerative medicine as part of…
Discovery Hailed As Step Toward Patient-Specific Treatments for Diabetes, Other Degenerative Diseases NEW YORK, NY (December 9, 2011) – TIME magazine has designated research conducted in the laboratory of the New York Stem Cell Foundation (NYSCF) as the #1 Medical Breakthrough of the year. TIME cited research led by NYSCF…
New York Stem Cell Foundation, Harvard Stem Cell Institute Announce Joint Effort to Accelerate Drug Discovery NEW YORK, N.Y. (Nov. 17, 2011) -- The New York Stem Cell Foundation (NYSCF) and the Harvard Stem Cell Institute (HSCI) today announced a joint effort to accelerate promising new treatments for devastating diseases…
New York Stem Cell Foundation Scientists to Use Stem Cell Technology to Develop Treatments for Diseases, Increase Blood Supply in Collaboration with New York Blood Center, Duke's Carolinas Cord Blood Bank, National Institutes of Health NEW YORK, NY (Nov. 2, 2011) – Scientists at the New York Stem Cell Foundation (NYSCF) will…
The New York Stem Cell Foundation (NYSCF) announced today that a British stem cell scientist working to cure blindness will be the first recipient of The New York Stem Cell Foundation – Robertson Prize in Stem Cell Research, a $200,000 prize awarded annually for extraordinary achievement in translational stem cell…
The New York Stem Cell Foundation (NYSCF) today named seven of the nation’s most promising young scientists as its 2011 class of NYSCF – Robertson Investigators. Each of the NYSCF Investigators will receive $1.5 million over the next five years to expand their own laboratories, train other scientists and foster…
As reported on October 5th in Nature, for the first time scientists have derived embryonic stem cells from individual patients by adding the nuclei of adult skin cells from patients with type 1 diabetes to unfertilized donor oocytes. A team of scientists led by Dieter Egli and Scott Noggle at…
National and international leaders in translational stem cell research will present their latest research findings on how advances in stem cell science will eventually lead to better treatments for persons suffering from debilitating chronic diseases and injuries at The New York Stem Cell Foundation’s (NYSCF) Sixth Annual Translational Stem Cell…
The New York Stem Cell Foundation has received a half million dollar gift from the Golub family to launch the NYSCF - Golub Stem Cell Initiative for Parkinson's Disease. The initiative permits researchers in the NYSCF Laboratory to use a novel approach to understand Parkinson's disease that includes the creation…
